A. Soro‐Paavonen

发表

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2008, Diabetes.

New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes

Benjamin J. Keller, Cameron D. Palmer, A. Paterson, 2012, PLoS genetics.

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications

Merlin C. Thomas, D. Gordin, C. Forsblom, 2012, Journal of hypertension.

Oxygen deteriorates arterial function in type 1 diabetes

D. Gordin, C. Forsblom, P. Groop, 2016, Acta Diabetologica.

Overproduction of large VLDL particles is driven by increased liver fat content in man

A. Häkkinen, J. Borén, M. Taskinen, 2006, Diabetologia.

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

A. Häkkinen, J. Borén, M. Taskinen, 2007, Diabetologia.

Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.

N. Lundbom, M. Taskinen, L. V. Van Gaal, 2009, European journal of endocrinology.

USF1 and dyslipidemias: converging evidence for a functional intronic variant.

L. Peltonen, M. Taskinen, P. Pajukanta, 2005, Human molecular genetics.

Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)

L. Peltonen, R. Cantor, M. Laakso, 2004, Nature Genetics.

RAGE biology, atherosclerosis and diabetes.

A. Soro-Paavonen, K. Jandeleit-Dahm, D. P. Barlovič, 2011, Clinical science.

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

T. Walther, M. Cooper, K. Sourris, 2010, Diabetologia.

THE AGE/RAGE AXIS IN DIABETES‐ACCELERATED ATHEROSCLEROSIS

A. Soro-Paavonen, K. Jandeleit-Dahm, A. Watson, 2008, Clinical and experimental pharmacology & physiology.

Glycosylation inhibitors, PKC inhibitors and related interventions against complications

M. Cooper, A. Soro-Paavonen, A. Soro‐Paavonen, 2007 .

AGE-RAGE signalling in endothelial dysfunction and atherosclerosis in diabetes

A. Soro-Paavonen, K. Jandeleit-Dahm, A. Watson, 2010 .

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

M. Taskinen, C. Ehnholm, A. Soro-Paavonen, 2006, Mediators of Inflammation.

Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDLs⃞ Published, JLR Papers in Press, March 19, 2007.

L. Peltonen, M. Taskinen, M. Jauhiainen, 2007, Journal of Lipid Research.

Metabolic and genetic determinants of HDL in families with low HDL cholesterol and premature coronary heart disease

A. Soro-Paavonen, A. Soro‐Paavonen, 2004 .

CHOLESTEROL AND PREMATURE CORONARY HEART DISEASE

A. Soro-Paavonen, A. Soro‐Paavonen, 2004 .

Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemia Published, JLR Papers in Press, July 16, 2004. DOI 10.1194/jlr.M400141-JLR200

L. Peltonen, M. Perola, E. Sobel, 2004, Journal of Lipid Research.

Hypertriglyceridemia is associated with preβ-HDL concentrations in subjects with familial low HDL Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.M400480-JLR200

M. Taskinen, M. Jauhiainen, C. Ehnholm, 2005, Journal of Lipid Research.

Hypertriglyceridemia is associated with pre (cid:1) -HDL concentrations in subjects with familial low HDL

M. Taskinen, M. Jauhiainen, C. Ehnholm, 2005 .

A male-specific quantitative trait locus on 1p21 controlling human stature

L. Peltonen, M. Perola, L. Groop, 2005, Journal of Medical Genetics.

Metabolic syndrome aggravates the increased endothelial activation and low‐grade inflammation in subjects with familial low HDL

M. Taskinen, C. Ehnholm, J. Westerbacka, 2006, Annals of medicine.

Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism.

L. Peltonen, R. Cantor, V. Salomaa, 2006, Human molecular genetics.

Decreased High-Density Lipoprotein (HDL) Particle Size, Pre&bgr;-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness

M. Taskinen, T. Tuomainen, R. Salonen, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

M. Cooper, A. Calkin, A. Soro-Paavonen, 2011, Diabetologia.

Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2012, Diabetes.

Influence of Postprandial Hyperglycemic Conditions on Arterial Stiffness in Patients With Type 2 Diabetes.

D. Gordin, C. Forsblom, P. Groop, 2016, The Journal of clinical endocrinology and metabolism.

Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2010, Journal of hypertension.

Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 Diabetes

Merlin C. Thomas, D. Gordin, C. Forsblom, 2014, Diabetes Care.

Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.

N. Lundbom, M. Taskinen, L. V. Van Gaal, 2009, European journal of endocrinology.

THE AGE/RAGE AXIS IN DIABETES‐ACCELERATED ATHEROSCLEROSIS

K. Jandeleit-Dahm, A. Watson, A. Soro‐Paavonen, 2008, Clinical and experimental pharmacology & physiology.

Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. Diabetes Care 2013;36:1827–1833

D. Gordin, C. Forsblom, P. Groop, 2013, Diabetes Care.

Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes

Merlin C. Thomas, D. Gordin, C. Forsblom, 2013, Diabetes Care.